Adaptability and flexibility of HIV‐1 protease
- 24 February 2003
- journal article
- Published by Wiley in European Journal of Biochemistry
- Vol. 270 (6) , 1231-1239
- https://doi.org/10.1046/j.1432-1033.2003.03483.x
Abstract
Even though more than 200 three-dimensional structures of HIV-1 protease complexed to a variety of inhibitors are available in the Protein Data Bank; very few structures of unliganded protein have been determined. We have recently solved structures of unliganded HIV-1 protease tethered dimer mutants to resolutions of 1.9 A and 2.1 A, and have found that the flaps assume closed-flap conformation even in the absence of any bound ligand. We report comparison of the unliganded closed-flap structure with structures of HIV-1 protease inhibitor complexes with a view to accurately identifying structural changes that the ligand can induce on binding to HIV-1 protease in the crystal. These studies reveal that the least flexible region present in the active site of HIV-1 protease need not also be the least adaptable to external stress, thus highlighting the conceptual difference between flexibility and adaptability of proteins in general.Keywords
This publication has 16 references indexed in Scilit:
- Effects of remote mutation on the autolysis of HIV-1 PR: X-ray and NMR investigationsBiochemical and Biophysical Research Communications, 2002
- Relation between sequence and structure of HIV-1 protease inhibitor complexes: a model system for the analysis of protein flexibilityJournal of Molecular Biology, 2002
- 1.9 x-ray study shows closed flap conformation in crystals of tethered HIV-1 PRProteins-Structure Function and Bioinformatics, 2001
- The Protein Data BankNucleic Acids Research, 2000
- Structural and kinetic analysis of drug resistant mutants of HIV‐1 proteaseEuropean Journal of Biochemistry, 1999
- Structural Basis for Specificity of Retroviral ProteasesBiochemistry, 1998
- Improved cyclic urea inhibitors of the HIV-1 protease: synthesis, potency, resistance profile, human pharmacokinetics and X-ray crystal structure of DMP 450Chemistry & Biology, 1996
- Three‐dimensional solution structure of the HIV‐1 protease complexed with DMP323, a novel cyclic urea‐type inhibitor, determined by nuclear magnetic resonance spectroscopyProtein Science, 1996
- Cyclic HIV Protease Inhibitors: Synthesis, Conformational Analysis, P2/P2‘ Structure−Activity Relationship, and Molecular Recognition of Cyclic UreasJournal of Medicinal Chemistry, 1996
- Rational Design of Potent, Bioavailable, Nonpeptide Cyclic Ureas as HIV Protease InhibitorsScience, 1994